Commenting on the decision today (6 August 2013) by the National Institute for Health and Clinical Excellence (NICE) not to recommend pertuzumab (...

6 August 2013

Commenting on the decision today (8 July 2013) by the National Institute for Health and Clinical Excellence (NICE) not to recommend everolimus (also...

8 July 2013

Commenting on the new NICE guidance on familial breast cancer: Classification and care of people at risk of familial breast cancer and management...

25 June 2013

Tuesday 14 May 2013 Contact: Sophie Softley Pierce/Sophie Howells sophie.pierce@breastcancercare.org.uk/ sophie.howells@breastcancercare.org.uk...

14 May 2013

The number of younger women diagnosed with breast cancer has topped 10000 a year for the first time according to news stories today. The figure is...

3 May 2013

Commenting on new statistics from Cancer Research UK released today (Friday 3 May 2013) showing that breast cancer in women under 50 has exceeded...

3 May 2013

Commenting on the decision today by the National Institute for Health and Clinical Excellence not to recommend everolimus (also known as Afinitor and...

21 March 2013

Breast Cancer Care comments on new treatment for advanced HER2-positive breast cancer patients as Perjeta (pertuzumab) gets regulatory green light....

14 March 2013

Breast Cancer Care comments on research carried out by the University of Sussex and Brighton & Sussex Medical School published in Annals of...

1 March 2013